Published in Dis Model Mech on November 07, 2014
Angiogenesis in life, disease and medicine. Nature (2005) 15.36
Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell (2010) 7.59
HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol (2001) 5.59
Classical nuclear localization signals: definition, function, and interaction with importin alpha. J Biol Chem (2006) 5.34
HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev (2009) 5.24
Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension. J Biol Chem (1997) 4.43
Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci U S A (2001) 3.88
Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes. Lancet (2014) 3.72
Diabetic foot ulcers. Lancet (2003) 3.03
Inducibility and negative autoregulation of CREM: an alternative promoter directs the expression of ICER, an early response repressor. Cell (1993) 2.84
Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat Med (2007) 2.23
A general strategy for isolation of endothelial cells from murine tissues. Characterization of two endothelial cell lines from the murine lung and subcutaneous sponge implants. Arterioscler Thromb Vasc Biol (1997) 2.15
Differential alphav integrin-mediated Ras-ERK signaling during two pathways of angiogenesis. J Cell Biol (2003) 1.93
Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2. Cold Spring Harb Perspect Med (2012) 1.68
NF-kappaB balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacement. Blood (2010) 1.64
Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67(MIB-5) immunohistochemistry and in situ hybridization for histone mRNA. J Histochem Cytochem (2003) 1.62
CREB: a multifaceted regulator of neuronal plasticity and protection. J Neurochem (2010) 1.58
cAMP-responsive element-binding protein regulates vascular endothelial growth factor expression: implication in human prostate cancer bone metastasis. Oncogene (2007) 1.58
Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment. Mol Cell Biol (1999) 1.45
A positive feedback loop of phosphodiesterase 3 (PDE3) and inducible cAMP early repressor (ICER) leads to cardiomyocyte apoptosis. Proc Natl Acad Sci U S A (2005) 1.34
Fractalkine stimulates angiogenesis by activating the Raf-1/MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways. Am J Physiol Heart Circ Physiol (2006) 1.28
Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1α protein-dependent mechanism. Int J Cancer (2010) 1.21
Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Eur J Pharmacol (2005) 1.20
Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1α, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3. J Biol Chem (2011) 1.20
Increasing GLP-1-induced beta-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-alpha and DUSP14. Diabetes (2007) 1.20
Role of glucocorticoids and cAMP-mediated repression in limiting corticotropin-releasing hormone transcription during stress. J Neurosci (2005) 1.14
mTOR links incretin signaling to HIF induction in pancreatic beta cells. Proc Natl Acad Sci U S A (2011) 1.14
Increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges in SPARC-null mice. Wound Repair Regen (2002) 1.11
The role of thrombospondins in wound healing, ischemia, and the foreign body reaction. J Cell Commun Signal (2009) 1.11
Impaired angiogenesis in aging is associated with alterations in vessel density, matrix composition, inflammatory response, and growth factor expression. J Histochem Cytochem (2003) 1.10
PGE2 promotes angiogenesis through EP4 and PKA Cγ pathway. Blood (2011) 1.10
Angiogenesis assays: problems and pitfalls. Cancer Metastasis Rev (2000) 1.10
Effects of aging on angiogenesis. Circ Res (2012) 1.10
Inducible cAMP early repressor (ICER) and brain functions. Mol Neurobiol (2009) 1.08
Imbalance of angiogenesis in diabetic complications: the mechanisms. Int J Prev Med (2012) 1.07
Impaired TGF-β signaling and a defect in resolution of inflammation contribute to delayed wound healing in a female rat model of type 2 diabetes. Mol Biosyst (2011) 1.06
RGS13 acts as a nuclear repressor of CREB. Mol Cell (2008) 1.02
Forskolin increases angiogenesis through the coordinated cross-talk of PKA-dependent VEGF expression and Epac-mediated PI3K/Akt/eNOS signaling. Cell Signal (2009) 0.98
Diabetic angiopathy and angiogenic defects. Fibrogenesis Tissue Repair (2012) 0.96
Emerging role of PKA/eNOS pathway in therapeutic angiogenesis for ischaemic tissue diseases. Cardiovasc Res (2012) 0.96
A defect in Nrf2 signaling constitutes a mechanism for cellular stress hypersensitivity in a genetic rat model of type 2 diabetes. Am J Physiol Endocrinol Metab (2011) 0.95
Age-associated reduction of nuclear protein import in human fibroblasts. Biochem Biophys Res Commun (2002) 0.93
Role for inducible cAMP early repressor in promoting pancreatic beta cell dysfunction evoked by oxidative stress in human and rat islets. Diabetologia (2011) 0.92
Cerebral neovascularization in diabetes: implications for stroke recovery and beyond. J Cereb Blood Flow Metab (2014) 0.91
Pharmacological and genetic accumulation of hypoxia-inducible factor-1alpha enhances excitatory synaptic transmission in hippocampal neurons through the production of vascular endothelial growth factor. J Neurosci (2010) 0.91
Mechanisms controlling the expression of the components of the exocytotic apparatus under physiological and pathological conditions. Biochem Soc Trans (2006) 0.90
Kinetic properties of nuclear transport conferred by the retinoblastoma (Rb) NLS. J Cell Biochem (2005) 0.89
Glucocorticoid dynamics and impaired wound healing in diabetes mellitus. Am J Pathol (1998) 0.88
Inflammation and apoptosis in aortic tissues of aged type II diabetes: amelioration with alpha-lipoic acid through phosphatidylinositol 3-kinase/Akt- dependent mechanism. Life Sci (2010) 0.86
Critical role of transcription factor cyclic AMP response element modulator in beta1-adrenoceptor-mediated cardiac dysfunction. Circulation (2008) 0.85
Pioglitazone inhibits HIF-1α-dependent angiogenesis in rats by paracrine and direct effects on endothelial cells. J Mol Med (Berl) (2014) 0.84
Deregulation of CREB signaling pathway induced by chronic hyperglycemia downregulates NeuroD transcription. PLoS One (2012) 0.84
Insulin and glucocorticoid-dependent suppression of the IGF-I system in diabetic wounds. Surgery (2000) 0.83
Impaired angiogenesis in aging myocardial microvascular endothelial cells is associated with reduced importin alpha and decreased nuclear transport of HIF1 alpha: mechanistic implications. J Physiol Pharmacol (2010) 0.83
What can wound fluids tell us about the venous ulcer microenvironment? Int J Low Extrem Wounds (2002) 0.80
Functional analysis of transcription factors CREB and CREM. Methods Enzymol (2003) 0.80
Superbug demands organizational change of the healthcare system. J Pharmacol Pharmacother (2011) 0.80
Caveolin-1/PTRF upregulation constitutes a mechanism for mediating p53-induced cellular senescence: implications for evidence-based therapy of delayed wound healing in diabetes. Am J Physiol Endocrinol Metab (2013) 0.80
Differences in histochemical characteristics of gingival collagen after ER:YAG laser periodontal plastic surgery. J Clin Laser Med Surg (2000) 0.79
The GSK-3β/Fyn/Nrf2 pathway in fibroblasts and wounds of type 2 diabetes: On the road to an evidence-based therapy of non-healing wounds. Adipocyte (2012) 0.79
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead. Carcinogenesis (2015) 0.95
Causes of genome instability: the effect of low dose chemical exposures in modern society. Carcinogenesis (2015) 0.86
Environmental immune disruptors, inflammation and cancer risk. Carcinogenesis (2015) 0.86
Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis? Carcinogenesis (2015) 0.85
The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signalling. Carcinogenesis (2015) 0.81
Disruptive chemicals, senescence and immortality. Carcinogenesis (2015) 0.78
Mechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression. Carcinogenesis (2015) 0.77
Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death. Carcinogenesis (2015) 0.77